TAICHUNG, TAIWAN (December 16, 2011) --Bio-medical Carbon Technology, a leading global wound dressing developer and manufacturer, announced today it received Class II clearance from the Taiwan Food and Drug Administration (TFDA) for its BCT Antimicrobial Dressing. The dressing, which comprised silver-coated activated carbon fiber cloth, can treat a broad range of wound types.
“The clearance of BCT Antimicrobial Dressing marks an important milestone in the care of patients with burns, diabetics and pressure ulcers and surgical wounds. We are excited to bring this dressing to the market and proud of our professional team in the continued pursuit of effective wound dressing.”
BCT Antimicrobial Dressing is an antimicrobial hydrophilic dressing. The dressing is developed by patented silver coating technology with activated carbon fibers. The dressing can be used on both acute and chronic wounds.
About Bio-medical Carbon Technology
Bio-medical Carbon Technology, BCT, develops and manufactures ionic silver coated activated carbon fiber wound care dressings. Its products with proven effectiveness backed by the laboratory tests and clinical trials can treat a broad range of wound types, both acute and chronic wounds. It is proven that its products provide an easy, gentle, faster wound healing. BCT operates worldwide and is supported by its professionals and ongoing development and research. For more information, please visit www.bm-carbon.com